P-AA-NLC (32 mg·kg−1) significantly reduced serum ALT, AST, and liver tissue MDA levels in CCl4-induced hepatic fibrosis rats, thereby ameliorating liver fibrosis. The gene discussed is GPT; the disease is Hepatic fibrosis.